Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2026-05-21 @ 12:47 AM
Study NCT ID:
NCT06101134
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-14
First Post:
2023-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations
Sponsor:
Organization: